[New aspects of the management of progressive muscular dystrophy].
D000227:Adenine Nucleotides / Q000627:therapeutic use; D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000328:Adult; D002648:Child; D005260:Female; D006150:Guanine Nucleotides / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009136:Muscular Dystrophies / Q000188:drug therapy*; D009705:Nucleosides / Q000627:therapeutic use*; D009711:Nucleotides / Q000627:therapeutic use*; D014529:Uridine / Q000627:therapeutic use
D000227:Adenine Nucleotides; D006150:Guanine Nucleotides; D009705:Nucleosides; D009711:Nucleotides; D000255:Adenosine Triphosphate; D014529:Uridine
Neue Aspekte der Behandlung der progressiven Muskeldystrophie.